Scientific publications on lymphomas

The results and conclusions of the work conducted by the Lymphoma Research Experts ecosystem are published in leading medical journals.

Lysa 2022_LYSA_Systematic review reveals urgent need to homogenize endpoints choices and definitions in marginal zone lymphomas trials
Côme Bommier, Mathilde Ruggiu, Aymeric Monégier, Emanuele Zucca, Catherine Thieblemont, Jérôme Lambert
DOI: 10.1080/10428194.2022.2032038 Learn more
Lysa 2022_LYSA_Chemotherapy-free treatment in unfit patients aged 75 years and older with DLBCL: toward a new paradigm?
Fabrice Jardin, Hervé Tilly
DOI: 10.1016/S2666-7568(22)00150-7 Learn more
Lysa 2022_LYSA_Peripheral T-Cell Lymphomas: Therapeutic Approaches
David Sibon
DOI: 10.3390/cancers14092332 Learn more
Lysa 2022_LYSA_The EHA Research Roadmap: Malignant Lymphoid Diseases
Martin Dreyling, Marc André, Nicola Gökbuget, Hervé Tilly, Mats Jerkeman, John Gribben, Andrés Ferreri, Pierre Morel, Stephan Stilgenbauer, Christopher Fox, José Maria Ribera, Sonja Zweegman, Igor Aurer, Csaba Bödör, Birgit Burkhardt, Christian Buske, Maria Dollores Caballero, Elias Campo, Bjoern Chapuy, Andrew Davies, Laurence de Leval, Jeanette Doorduijn, Massimo Federico, Philippe Gaulard, Francesca Gay, Paolo Ghia, Kirsten Grønbæk, Hartmut Goldschmidt, Marie-Jose Kersten, Barbara Kiesewetter, Judith Landman-Parker, Steven Le Gouill, Georg Lenz, Sirpa Leppä, Armando Lopez-Guillermo, Elizabeth Macintyre, Maria Victoria Mateos Mantega, Philippe Moreau, Carol Moreno, Bertrand Nadel, Jessica Okosun, Roger Owen, Sarka Pospisilova, Christiane Pott, Tadeusz Robak, Michelle Spina, Kostas Stamatopoulos, Jan Stary, Karin Tarte, Allessandra Tedeschi, Catherine Thieblemont, Ralf Ulrich Trappe, Lorenz H. Trümper, Gilles Salles
DOI: 10.1097/HS9.0000000000000726 Learn more
Lysa 2022_LYSA_Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality
Adrien Krug, Gamze Tari, Aymen Saidane, Philippe Gaulard, Jean-Ehrland Ricci, François Lemonnier, Els Verhoeyen
DOI: 10.3390/cancers14102392 Learn more
Lysa 2022_LYSA_Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients
Matthew R. Wilson, Toby A. Eyre, Amy A. Kirkwood, Nicole Wong Doo, Carole Soussain, Sylvain Choquet, Nicolás Martinez-Calle, Gavin Preston, Matthew Ahearne, Elisabeth Schorb, Marie-Pierre Moles-Moreau, Matthew Ku, Chiara Rusconi, Jahanzaib Khwaja, Mayur Narkhede, Katharine L. Lewis, Teresa Calimeri, Eric Durot, Loïc Renaud, Andreas Kiesbye Øvlisen, Graham McIlroy, Timothy J. Ebsworth, Johnathan Elliot, Anna Santarsieri, Laure Ricard, Nimish Shah, Qin Liu, Adam S. Zayac, Francesco Vassallo, Laure Lebras, Louise Roulin, Naelle Lombion, Kate Manos, Ruben Fernandez, Nada Hamad, Alberto Lopez-Garcia, Deirdre O'Mahony, Praveen Gounder, Nathalie Forgeard, Charlotte Lees, Kossi Agbetiafa, Tim Strüßmann, Thura Win Htut, Aline Clavert, Hamish Scott, Anna Guidetti, Brett R. Barlow, Emmanuelle Tchernonog, Jeffery Smith, Fiona Miall, Christopher P. Fox, Chan Y. Cheah, Tarec Christoffer El Galaly, Andrés J. M. Ferreri, Kate Cwynarski, Pamela McKay
DOI: 10.1182/blood.2021014506 Learn more
Lysa 2022_LYSA_The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target‑Mediated Drug Disposition
Amina Bensalem, Guillaume Cartron, Ulrich Specks, Denis Mulleman, Emmanuel Gyan, Divi Cornec, Celine Desvignes, Olivier Casasnovas, Thierry Lamy, Stéphane Leprêtre, Gilles Paintaud, David Ternant
DOI: 10.1007/s40262-021-01081-3 Learn more
Lysa 2022_LYSA_Chapter 22: Bridging Chemotherapy: Relapsed/Refractory Aggressive B-Cell Lymphoma
Catherine Thieblemont, Peter Borchmann
DOI: 10.1007/978-3-030-94353-0_22 Learn more
Lysa 2022_LYSA_Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
Kamel Laribi, Alix Baugier de Materre, Yamina Touileb, Charles Boursot, Jeremy Sandrini, Doriane Cavalieri, Cédric Pastoret, Laurence de Leval, Olivier Tournilhac
DOI: 10.1097/HS9.0000000000000675 Learn more
Lysa 2022_LYSA_What Prognostic Markers Should Be Evaluated in Marginal Zone Lymphoma? A Survey Among Leading International Experts
Côme Bommier, Jérôme Lambert, Grzegorz Nowakowski, Emanuele Zucca, Catherine Thieblemont
DOI: 10.1097/HS9.0000000000000680 Learn more
Lysa 2022_LYSA_PET imaging: back in the game for gastric EMZL?
Anne-Ségolène Cottereau
doi: 10.1182/blood.2021013964. Learn more
Lysa 2022_LYSA_Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study
René-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, Julien Lazarovici, Hervé Ghesquieres, Aspasia Stamatoullas, Jehan Dupuis, Anne-Claire Gac, Thomas Gastinne, Bertrand Joly, Krimo Bouabdallah, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Franck Morschhauser, David Sibon, Christophe Bonnet, Alina Berriolo-Riedinger, Véronique Edeline, Marie Parrens, Diane Damotte, Diane Coso, Marc André, Michel Meignan, Cédric Rossi
J Clin Oncol 2022 Jan 6;JCO2101777. doi: 10.1200/JCO.21.01777 Learn more
Lysa 2022_LYSA_Obinutuzumab plus lenalidomide (GALEN) in advanced, previously untreated follicular lymphoma in need of systemic therapy
Emmanuel Bachy, Roch Houot, Pierre Feugier, Krimo Bouabdallah, Reda Bouabdallah, Emmanuelle Nicolas-Virelizier, Marie M F Maerevoet, Christophe Fruchart, Sylvia Snauwaert, Steven Le Gouill, Jean-Pierre Marolleau, Lysiane Molina, Cécile Moluçon Chabrot, Catherine Thieblemont, Herve Tilly, Fontanet Bijou, Corinne Haioun, Eric W Van Den Neste, Bettina Fabiani, Michel Meignan, Guillaume Cartron, Gilles Andre Salles, Rene-Olivier Casasnovas, Franck Morschhauser
Blood . 2022 Apr 14;139(15):2338-2346. Learn more
Lysa 2021_LYSA_The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA
Lieselot Buedts, Iwona Wlodarska, Julio Finalet-Ferreiro, Olivier Gheysens, Luc Dehaspe, Thomas Tousseyn, Luc-Matthieu Fornecker, Julien Lazarovici, Rene-Olivier Casasnovas, Anne-Claire Gac, Christophe Bonnet, Kamal Bouabdallah, Christiane Copie-Bergman, Bettina Fabiani, Daan Dierickx, Lukas Marcelis, Joris Vermeesch, Marc Andre, Peter Vandenberghe
Blood Advances 2021 Learn more
Lysa 2021_LYSA_Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides linger disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from LyMA prospective trial
Benoit Tessoulin, David Chiron, Catherine Thieblemont, Lucie Oberic, Kamal Bouadballah, Emmanuel Gyan, Gandhi Damaj, Vincent Ribrag, Rémy Gressin, Pierre Feugier, Olivier Casasnovas, Hacène Zerazhi, François Lemonnier, Hervé Maisonneuve, Clementine Joubert, Eric Van Den Neste, Thierry Lamy, Hervé TIlly, Anne Moreau, Olivier Hermine, Steven Le Gouill
Bone Marrow Transplant . 2021 Jul;56(7):1700-1709. Learn more
Lysa 2021_LYSA_Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies
Lucile Bussot, Simon Chevalier,Justine Cristante, Béatrice Grange,Bruno Tesson, Clémence Deteix-Santana, Frédérique Orsini-Piocelle, Cécile Leyronnas, Sophie Dupire, Rémy Gressin,Gilles Salles, Emmanuel Bachy, Anouk Emadali, Séverine Valmary-Degano, Sarah Huet, Christine Lefebvre and Sylvain Carras
Br J Haematol . 2021 Jul;194(2):382-392. Learn more
Lysa 2021_LYSA_Extracellular vesicles shed by follicular lymphoma B cells promote polarization of the bone marrow stromal cell niche
Erwan Dumontet, Céline Pangault, David Roulois, Matthis Desoteux, Simon Léonard, Tony Marchand, Maelle Latour, Patricia Legoix, Damarys Loew, Florent Dingli, Joelle Dulong, Erwan Flecher, Cédric Coulouarn, Guillaume Cartron, Thierry Fest, Karin Tarte
Blood . 2021 Jul 8;138(1):57-70. Learn more
Lysa 2021_LYSA_Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP
Sophie Bernard, Herve Ghesquieres, Rene-Olivier Casasnovas, Samuel Griolet, Maria Gomes da Silva, Pierre Feugier, Franck Morschhauser, Judith Trotman, Loic Renaud, Richard Greil, Alejandro Martin Garcia-Sancho, Sebastian Grosicki, Koen van Eygen, Christiane Copie-Bergman, Corinne Haioun, Catherine Thieblemont
Blood Adv . 2021 Aug 10;5(15):2965-2968. Learn more
Lysa 2021_LYSA_High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B
Camille Laurent, José Adélaïde, Arnaud Guille, Bruno Tesson, Elodie Gat, Solene Evrard, Frederic Escudié, Charlotte Syrykh, Danielle Canioni, Bettina Fabiani, Véronique Meignin, Catherine Chassagne-Clement , Peggy Dartigues, Alexandra Traverse-Glehen, Marie Parrens, Sarah Huet, Christiane Copie-Bergman, Gilles Salles, Daniel Birnbaum, Pierre Brousset, Franck Morschhauser, Luc Xerri, Lymphoma Study Association (LYSA)
Am J Surg Pathol . 2021 Oct 1;45(10):1324-1336. Learn more
Lysa 2021_LYSA_Outcomes after first-line immunochemotherapy for primary mediastinal B cell lymphoma patients: a LYSA study
Vincent Camus, Cédric Rossi, Pierre Sesques, Justine Lequesne, David Tonnelet, Corinne Haioun, Eric DUROT, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles-Moreau, Chloe Antier, Julien Lazarovici, Helene Monjanel, Sophie Bernard, Magalie Pascale Tardy, Caroline Besson, Laure Lebras, Sylvain Choquet, Katell Le Dû, Christophe Bonnet, Sarah Bailly, Gandhi Damaj, Kamel Laribi, Herve Gerard Maisonneuve, Roch Houot, Adrien Chauchet, Fabrice Jardin, Alexandra Traverse-Glehen, Pierre Decazes, Stéphanie Becker, Alina Berriolo-Riedinger, Herve Tilly
Blood Adv . 2021 Oct 12;5(19):3862-3872. Learn more
Lysa 2021_LYSA_Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)
Demeestere I, Racape J, Dechene J, Dupuis J, Morschhauser F, De Wilde V, Lazarovici J, Ghesquieres H, Touati M, Sibon D, Alexis M, Gac AC, Moatti H, Virelizier E, Maisonneuve H, Pranger D, Houot R, Fornecker LM, Tempescul A, André M, Casasnovas RO.
J Clin Oncol . 2021 Oct 10;39(29):3251-3260. Learn more
Lysa 2021_LYSA_Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumor volume prediction using a convolutional neural network
Paul Blanc-Durand, Simon Jégou, Salim Kanoun, Alina Berriolo-Riedinger, Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Thomas Carlier, Steven Le Gouill, René-Olivier Casasnovas, Michel Meignan, Emmanuel Itti
Eur J Nucl Med Mol Imaging . 2021 May;48(5):1362-1370. doi: 10.1007/s00259-020-05080-7. Learn more
Lysa 2021_LYSA_Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA
Steven Le Gouill, Hervé Ghesquières, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Thierry Lamy, Catherine Thieblemont, Hervé Maisonneuve, Rémy Gressin, Krimo Bouabdallah, Corinne Haioun, Gandhi Damaj, Luc Fornecker, Réda Bouabdallah, Pierre Feugier, David Sibon, Guillaume Cartron, Christophe Bonnet, Marc André, Loic Chartier, Philippe Ruminy, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Alina Berriolo-Riedinger, Josette Brière, Jean-Philippe Jais, Thierry Jo Molina, Emmanuel Itti, René-Olivier Casasnovas.
Blood . 2021 Apr 29;137(17):2307-2320. doi: 10.1182/blood.2020008750. Learn more
Lysa 2021_LYSA_Lenalidomide tiggers T-cell effector functions in vivo in patients with follicular lymphoma
Cédric Ménard, Delphine Rossille, Joelle Dulong, Tien-Tuan Nguyen, Ilenia Papa, Maelle Latour, Nadège Bescher, Isabelle Bezier, Myriam Chouteau, Thierry Fest, Roch Houot, Franck Morshhauser, Karin Tarte
Blood Adv . 2021 Apr 27;5(8):2063-2074. Learn more